Pharma Journalist - Page 876 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA Accepts Rigel’s New Drug Application for TAVALISSE

Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg

Boehringer presents phase III results of adalimumab biosimilar candidate to HUMIRA

Johnson & Johnson Announces Completion of Acquisition of Actelion

Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline

Probiodrug announces encouraging results of the Phase 2a SAPHIR Study

Pfizer Receives Commercialization Rights in Europe for CRESEMBA

Generon announces the initiation of a Phase 1 Clinical Trial for A-337

LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Dermatitis

SGS Expands Extractables and Leachables Testing Capabilities at its Shanghai Facility